SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-030492
Filing Date
2022-02-08
Accepted
2022-02-08 08:27:53
Documents
2
Group Members
MEDICXI CO-INVEST I LPMEDICXI GROWTH CO-INVEST I LPMEDICXI GROWTH I GP LTDMEDICXI SECONDARY CO-INVEST I LPMEDICXI SECONDARY I GP LTDMEDICXI SECONDARY I LPMEDICXI VENTURES I GP LTDMEDICXI VENTURES I LPMEDICXI VENTURES MANAGEMENT (JERSEY) LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G d310416dsc13g.htm SC 13G 199537
2 EX-99.1 d310416dex991.htm EX-99.1 14785
  Complete submission text file 0001193125-22-030492.txt   216386
Mailing Address C/O ELIAN FUND SERVICES (JERSEY) LIMITED 44 ESPLANADE ST HELIER Y9 JE4 9WG
Business Address C/O ELIAN FUND SERVICES (JERSEY) LIMITED 44 ESPLANADE ST HELIER Y9 JE4 9WG 44 (0)1534 504343
Medicxi Growth I LP (Filed by) CIK: 0001690310 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9
Type: SC 13G

Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Subject) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92588 | Film No.: 22599370
SIC: 2834 Pharmaceutical Preparations